Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
35 studies found for:    " November 04, 2009":" December 04, 2009"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Completed S.T.A.R.S.: Sistas Talking About Real Solutions
Condition: HIV Prevention
Interventions: Behavioral: STARS: Sistas Talking About Real Solutions;   Behavioral: General Health & Nutrition
22 Completed Pharmacodynamics, Safety and Pharmacokinetics of BMS-663068, an HIV Attachment Inhibitor, in HIV-1
Condition: HIV-1 Infections
Intervention: Drug: BMS-663068 with or without ritonavir
23 Unknown  CD4-ZETA Gene Modified T Cells With and Without Exogenous Interleukin-2 (IL-2) In HIV Patients
Condition: HIV-1 Infections
Interventions: Drug: IL-2 (~1.2M IU/m2);   Biological: T Cell infusion 5-10 x E9 T cells
24 Completed Managerial Database II
Condition: HIV
Intervention: Other: Observation
25 Completed Exploration of HIV Reservoirs
Condition: HIV-1 Infection
Intervention: Procedure: Rectal mucosa biopsy
26 Completed Effect of HIV Infection and Highly Active Antiretroviral Treatment (HAART) on Bone Homeostasis
Conditions: HIV Infection;   Osteopenia;   Osteoporosis
Intervention:
27 Completed
Has Results
Trichomonas Vaginalis Recurrence Among HIV+ Women
Conditions: Trichomonas Infections;   HIV Infections
Intervention: Drug: Metronidazole
28 Completed Raltegravir in Patients With End Stage Liver Disease and in Transplant Recipients
Conditions: HIV Infection;   Liver Failure;   Evidence of Liver Transplantation
Intervention: Drug: Raltegravir potassium
29 Completed Vaccine Responses to Influenza A H1N1/09 Immunization in High-risk Patients
Conditions: HIV Infection;   Rheumatic Disease;   Cancer;   Transplant;   Pediatrics
Intervention: Biological: Adjuvanted influenza A(H1N1) vaccines
30 Active, not recruiting Bortezomib in Treating Patients With Relapsed or Refractory AIDS-Related Kaposi Sarcoma
Conditions: AIDS-Related Kaposi Sarcoma;   HIV Infection;   Recurrent Kaposi Sarcoma
Interventions: Drug: Bortezomib;   Other: Laboratory Biomarker Analysis;   Other: Questionnaire Administration
31 Terminated Safety and Immunogenicity of MVA.HIVconsv in HIV-1 Seropositive Adults on HAART
Condition: HIV-1
Interventions: Biological: MVA.HIVconsv low dose;   Other: Placebo low dose;   Biological: MVA.HIVconsv high dose;   Other: Placebo high dose
32 Completed Therapeutic Intensification Plus Immunomodulation in HIV-infected Patients
Condition: HIV-1 Infection
Interventions: Drug: ART Intensification;   Biological: Immunomodulation
33 Unknown  Maraviroc (Celsentri) With Raltegravir and Darunavir/Ritonavir for the Treatment of Triple Class Failure in Adult HIV-1 Infected Patients
Conditions: HIV-1 Adults Patients;   AIDS;   Triple Class Failure
Interventions: Drug: maraviroc;   Drug: Raltegravir;   Drug: Darunavir/ritonavir
34 Unknown  Safety and Immune Response to Adjuvanted A(H1N1)v Influenza Vaccine in HIV-1 Infected and Immunosuppressed Adult Patients
Conditions: HIV-1 Infection;   Cancer;   Immunosuppression
Intervention: Other: serologic testing
35 Completed Observational Study of the Preventive Trial With HIV-1 Tat Protein
Condition: Healthy Subjects
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-35) Next Page   
Study has passed its completion date and status has not been verified in more than two years.